Premature Battery Depletion – SJM ICD and CRT-D

HRS recommends that physicians contact all of their affected patients to reinforce the FDA’s recommendations and schedule office visits to discuss the details of the safety communication. Physicians, patients and their care-givers should determine the best course of action based on individuals’ medical history, comorbidities, and clinical conditions.

HRS strongly supports the FDA’s recommendation to employ remote monitoring to assist in the early detection of premature battery depletion. This is consistent with the recent HRS Expert Consensus Statement on Remote Interrogation and Monitoring for Cardiovascular Electronic Implantable Devices, which includes a Class I recommendation (level of evidence A) for monitoring all patients.